1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Hepatitis D Global Clinical Trials Review, H2, 2016

Hepatitis D Global Clinical Trials Review, H2, 2016

  • August 2016
  • -
  • Global Data
  • -
  • 56 pages

Hepatitis D Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Hepatitis D Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis D clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis D. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Hepatitis D Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2


Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hepatitis D Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Hepatitis D 30
Jul 20, 2016: Eiger BioPharmaceuticals Announces Completion of Dosing in Phase 2 LOWR HDV - 3 Study at National Institutes of Health 30
Jun 01, 2016: Maxwell Biotech Venture Fund's Portfolio Company Hepatera Announces Publication of Myrcludex B Clinical Results in Journal of Hepatology 30
May 25, 2016: Maxwell Biotech Venture Fund's Portfolio Company Hepatera Announces Start Of Second Phase 2 Clinical Trial Of Myrcludex B In Chronic Hepatitis B/D Infection 30
Clinical Trial Profile Snapshots 32
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 55
Contact Us 55
Disclaimer 55
Source 56

List of Tables
Hepatitis D Therapeutics, Global, Clinical Trials by Region, 2016* 6
Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Hepatitis D Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Hepatitis D Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Hepatitis D Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Hepatitis D Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures
Hepatitis D Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9
Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Hepatitis D Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 54

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
 Hepatitis D-Pipeline Insights, 2016

Hepatitis D-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Hepatitis D-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis D. The DelveInsight’sReport ...

Europe Molecular Blood Typing, Grouping and Infectious Disease Screening Market 2017-2021:  France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares

Europe Molecular Blood Typing, Grouping and Infectious Disease Screening Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares

  • $ 12800
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify ...

2016 Croatia Transfusion Diagnostics Market: Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

2016 Croatia Transfusion Diagnostics Market: Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

  • $ 1250
  • Industry report
  • October 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry ...


Download Unlimited Documents from Trusted Public Sources

Hepatitis Statistics in India

  • October 2016
    4 pages
  • Hepatitis  

    Hepatitis A  

  • India  

    Asia  

View report >

Infectious Disease Statistics

  • October 2016
    173 pages
  • Infectious Dise...  

    Anti-Infective  

  • United States  

    Asia  

    North America  

View report >

Pathology Statistics in Burkina Faso

  • October 2016
    4 pages
  • Pathology  

    Hepatitis  

  • Burkina Faso  

View report >

Hepatitis B Statistics

6 months ago

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.